Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
- DOI
- 10.1186/s10194-023-01688-w
- Published
- 2023 Nov 20
- Container
- The journal of headache and pain
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s10194-023-01688-w,
title = {Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.},
author = {Ashina M and Tepper SJ and Gendolla A and Sperling B and Ettrup A and Josiassen MK and Starling AJ},
year = {2023},
journal = {The journal of headache and pain},
doi = {10.1186/s10194-023-01688-w},
url = {https://doi.org/10.1186/s10194-023-01688-w}
}RIS
TY - JOUR TI - Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial. AU - Ashina M AU - Tepper SJ AU - Gendolla A AU - Sperling B AU - Ettrup A AU - Josiassen MK AU - Starling AJ PY - 2023 JO - The journal of headache and pain DO - 10.1186/s10194-023-01688-w UR - https://doi.org/10.1186/s10194-023-01688-w ER -
APA
M, A., SJ, T., A, G., B, S., A, E., MK, J., & AJ, S. (2023). Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.. The journal of headache and pain. https://doi.org/10.1186/s10194-023-01688-w
Source records
- pubmed · retrieved 2026-09-27T11:28:16.584Z